Liang Shen

Prof. Dr. Liang Shen


Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 August 2025 in Food Chemistry
Verified
Journal Article
Closed access
RGRu-Xue Guo
Ru-Xue Guo
LSLiang Shen
Liang Shen


1 May 2025 in Food Science & Nutrition
Verified
Journal Article
Open access
ZDZhaoyang Dong
Zhaoyang Dong
RZRan Zhang
Ran Zhang
LSLiang Shen
Liang Shen
HJHong‐Fang Ji
Hong‐Fang Ji
HHHaidong He
Haidong He
LZLiming Zhao
Liming Zhao
Immunoglobulin A nephropathy (IgAN) is a primary glomerular disease characterized by the deposition of IgA. The pathogenesis of it is related to the dysbiosis of gut microbiota. Dysbiosis of gut microbiota influences mucosal immune response and systemic immune system, leading to glycosylation‐deficient IgA1 (Gd‐IgA1) increasing, which promotes the development of IgAN. Diet plays an important role in regulating gut microbiota and treating IgAN. In this review, we summarize the interplay between gut microbiota and IgAN, and their underlying mechanisms. We also describe the effects of dietary intake on IgAN, as well as the composition of gut microbiota. The progress on IgAN treatment mainly focuses on inhibiting or regulating the immune system. Moreover, therapeutic strategies related to gut microbiota such as dietary intervention, supplement of probiotics and prebiotics, as well as fecal microbiota transplantation (FMT) have shown the possibility of improving IgAN prognosis. Thus, exploration of the gut‐kidney axis, the long‐term effects of diet and microbiome is necessary to develop more effective treatment strategies.

20 November 2025 in International Journal of Biological Macromolecules
Verified
Journal Article
Closed access
HZHui-Min Zhang
Hui-Min Zhang
LSLiang Shen
Liang Shen

9 October 2025 in Food & Function
Verified
Journal Article
Closed access
PDF file
HMHui-Ke Ma
Hui-Ke Ma
LSLiang Shen
Liang Shen
LZLiming Zhao
Liming Zhao
HJHong-Fang Ji
Hong-Fang Ji
In recent years, substantial attention has been paid to the use of dietary approaches to regulate the composition and metabolic activity of the gut microbiota. Dietary fibres (DFs), including resistant starch, non-starch polysaccharides, resistant oligosaccharides, and lignin, are known to have multifaceted beneficial effects on human health. This review discusses available studies on the regulative effects of resistant starch, non-starch polysaccharides, resistant oligosaccharides, and lignin on the gut microbiota, and the association with their health benefits. Firstly, a total of 89 studies are included in this review, comprising 71 animal studies, 9 human trials, and 9 in vitro experiments. Secondly, the health benefits of DFs are closely related to the overall modulation of the gut microbiota, by affecting microbial diversity, decreasing the ratio of Firmicutes/Bacteroidetes, and selectively enriching beneficial bacteria like Akkermansia, Bifidobacteria, and Ruminococcus. Thirdly, the populations of short-chain fatty acid (SCFA)-producing bacteria can be regulated by DFs, suggesting a potential role of SCFAs in health benefits. Additionally, the degradation mechanisms of DFs through polysaccharide utilization locus systems of the gut microbiota and the potential negative effects of excessive DF intake are briefly discussed. By providing a comprehensive overview, this review is expected to deepen the understanding of the regulation of the gut microbiota by DFs, which may inspire further studies for better DF application in health areas.

20 May 2025 in Industrial Crops and Products
Verified
Journal Article
Open access
XLXin-Yu Li
Xin-Yu Li
LSLiang Shen
Liang Shen
HJHong-Fang Ji
Hong-Fang Ji